Sweden
· Delayed Price · Currency is SEK AcuCort AB Statistics
Total Valuation
AcuCort AB has a market cap or net worth of SEK 171.84 million. The enterprise value is 169.07 million.
| Market Cap | 171.84M |
| Enterprise Value | 169.07M |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AcuCort AB has 226.11 million shares outstanding. The number of shares has increased by 219.67% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 226.11M |
| Shares Change (YoY) | +219.67% |
| Shares Change (QoQ) | +63.29% |
| Owned by Insiders (%) | 0.34% |
| Owned by Institutions (%) | 13.84% |
| Float | 214.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.27 |
| PB Ratio | 4.21 |
| P/TBV Ratio | 4.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.72 |
| EV / Sales | 21.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85
| Current Ratio | 0.85 |
| Quick Ratio | 0.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -84.64 |
Financial Efficiency
Return on equity (ROE) is -39.37% and return on invested capital (ROIC) is -19.39%.
| Return on Equity (ROE) | -39.37% |
| Return on Assets (ROA) | -16.51% |
| Return on Invested Capital (ROIC) | -19.39% |
| Return on Capital Employed (ROCE) | -33.57% |
| Revenue Per Employee | 2.57M |
| Profits Per Employee | -5.80M |
| Employee Count | 3 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.71% in the last 52 weeks. The beta is 1.39, so AcuCort AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | +35.71% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 0.86 |
| Relative Strength Index (RSI) | 51.15 |
| Average Volume (20 Days) | 353,414 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AcuCort AB had revenue of SEK 7.72 million and -17.40 million in losses.
| Revenue | 7.72M |
| Gross Profit | -8.39M |
| Operating Income | -13.71M |
| Pretax Income | -17.40M |
| Net Income | -17.40M |
| EBITDA | n/a |
| EBIT | -13.71M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 2.77 million in cash and n/a in debt, giving a net cash position of 2.77 million or 0.01 per share.
| Cash & Cash Equivalents | 2.77M |
| Total Debt | n/a |
| Net Cash | 2.77M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 40.85M |
| Book Value Per Share | n/a |
| Working Capital | -684,000 |
Cash Flow
| Operating Cash Flow | -20.15M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -108.76%, with operating and profit margins of -177.67% and -225.45%.
| Gross Margin | -108.76% |
| Operating Margin | -177.67% |
| Pretax Margin | -225.45% |
| Profit Margin | -225.45% |
| EBITDA Margin | n/a |
| EBIT Margin | -177.67% |
| FCF Margin | n/a |
Dividends & Yields
AcuCort AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -219.67% |
| Shareholder Yield | -219.67% |
| Earnings Yield | -10.12% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |